article thumbnail

Avalon Ventures Gets Exit At Sitari Pharmaceuticals

socalTECH

San Diego-based biotech investor Avalon Ventures has scored an exit, saying late Tuesday evening that it has entered into a definitive agreement with GlaxoSmithKline (GSK), to sell Sitari Pharmaceuticals to GSK. Sitari was developing treatments for celiac disease, and was being incubated at COI Pharmaceuticals.

Avalon 100
article thumbnail

Avalon Ventures Backs LoopIt

socalTECH

San Diego-based venture investment fund Avalon Ventures has made a seed investment in a developer of a social shopping service, LoopIt , according to the companies. and is a spinout of Redstar Ventures, a venture incubator firm in Cambridge. Avalon's Rich Levandov was involved in the investment.

Avalon 159
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck

Xconomy

Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Debuting in COI (which stands for “community of innovation”). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Avalon 73
article thumbnail

Nerio Therapeutics Finds $3.0M

socalTECH

The company appears to be another company emerging from COI Pharmaceutiacls , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, as Sanford Madigan, Jay Lichter, and Tighe Reardon are all listed as officers of the new company. in funding--in what looks to be an ongoing $5.7M

Avalon 113
article thumbnail

COI Pharmaceuticals Gets $576M Exit

socalTECH

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.

Avalon 124
article thumbnail

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

Xconomy

San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). Lilly Asia Ventures, Osage University Partners, and Vivo Capital joined in the deal, according to a statement from Avalon. 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40
article thumbnail

ScoreStream Nabs $2M For Local Sports Crowdsourcing

socalTECH

Also participating in the funding was Avalon Ventures, New Enterprise Associates, and angels, including Kevin Plank (Under Armour) and Paul Palmieri (Millennial Media). Oien was previously the CEO of Chumby; ScoreStream is part of the EvoNexus incubator. READ MORE>>.

Avalon 100